by Thaddeus Camlin, PsyD Labeling people who’ve been traumatized as sick, is sick. There’s nothing pathological about being severely affected by the worst of life’s horrors. There is something deeply pathological when natural reactions to unnatural situations are described as sickness and disease. There’s nothing sick or diseased about someone experiencing post-traumatic stress after catastrophic events then easing the aftershocks with substances that provide fast-acting relief. Substance use is an adaptive effort to cope with life problems, and until we figure out ways to effectively and reliably help people who suffer from post-traumatic stress people will continue to take matters into their own hands. The problem is not the people in addiction treatment, the problem is the woefull...

by Thaddeus Camlin, PsyD [caption id="attachment_12950" align="alignright" width="500"] HBO's Euphoria misses the mark when it comes to addiction, again[/caption] The latest installment of HBO’s Euphoria is chock-full of harmful addiction myths and contradicting information.  The show’s main character, Rue, is a young and intelligent woman with a history of severe trauma.  Her father died young from cancer, she was drugged and nearly raped, and she was cheated on and heartbroken by her first true love.  Like many who experience horrible trauma, Rue found solace in substances like MDMA and opiates.  Like many who find solace from trauma in substances, Rue got a bit carried away.  Like many who get a bit carried away with substances, Rue experienced some negative consequences becaus...

By Thaddeus Camlin, PsyD The urgent need for drug policy reform cannot be understated.  In the past few weeks, two stories about drug crime shone yet another spotlight on the lunacy of U.S. drug policy.  Oxycontin manufacturer Purdue Pharma plead guilty to three felony charges and incurred an $8 billion dollar fine for actions contributing to the deaths of nearly half a million Americans.  No owners or executives from Purdue Pharma, including the Sackler Family in charge, will serve any jail time (at least for now).  Many heralded the decision as justice served to the big pharma corporate conglomerate notorious for its strategically misleading information about the addictive properties of its potent opiate cash cow, oxycontin.  Meanwhile, a smaller story arose out of Georgia where Sa...

by Thaddeus Camlin, PsyD Few things scare big pharma like effective medicines people don’t have to take every day.  Many are familiar with the sardonic notion that there is no money in the cure.  The psychedelic treatment renaissance is arguably the biggest existential threat to big pharma’s decades-long chokehold on America’s addiction to psychotropic medications.  Patents on naturally occurring alkaloids are not permitted in the U.S., so for those looking to capitalize on the resurgence of effective plant medicines creative strategies must be employed.  Enter psilocybin sublingual strips.  A Toronto based company recently announced its efforts to develop a patentable delivery mechanism for the psychoactive compounds in magic mushrooms, namely, psilocybin and psilocyn.  Administ...

By Thaddeus Camlin, PsyD We know prohibition doesn’t stop drug use, actually makes the use of drugs more dangerous, and helps increase profit margins for those who control the black market.  We know that humans locked in cages for possessing psychoactive compounds deemed dangerous by the government are disproportionately people of color.  We know the United Nations Office on Drugs and Crime estimated the retail value of the illegal drug trade in 2005 alone to be $321 billion, nearly 1% of total global trade.  We know that people are hurting right now, that calls for social change are strong, that the economy is hurting, and that an efficiently functioning government helps in times of societal distress.  Ending drug prohibition is a concrete, achievable action step that would advance ...

by Thaddeus Camlin, Psy.D. We know now through research, experience, and common sense that all so-called "addicts" are not the same, and that addiction is not an intractable, lifelong condition that cannot be overcome.  At the heart of addictive problems a compromised capacity for self-regulation is often found. Self-regulation is not a genetic trait that some inherit and some do not - it is a skill developed and nurtured largely by the environment.  An expertise in horticulture is not required to understand that lacking conditions are the most likely explanation for an underwhelming harvest. The good news is that self-regulation can be developed and refined at any stage of life, and there are concrete factors that help us improve our capacity for it. Underdeveloped self-regulatio...

by Thaddeus Camlin, Psy.D. Earlier this year I wrote a piece arguing that 12-step programs are wrong when they claim that drug use invariably leads to jails, institutions, or death.  The piece generated a decent amount of dissenting responses (even more than most of the stuff I write!). Impassioned retorts proclaimed that I built a “straw man” argument by referring to drug use leading to jails, institutions, and death, and insisted that the 12-step programs only make the ominous claim about people in “active addiction.”  Inherent in the dissenting opinions is an implied agreement that the original article was correct in claiming that most substance use does not lead to jails, institutions, and death, so at least we agree on something. Now, let us narrow the focus from the fact that m...

by Thaddeus Camlin, Psy.D. They said acid fries your brain and makes you jump off buildings.  They said shrooms make your brain bleed and that’s why they cause hallucinations.  They said pot makes people murder their families.  I don’t know exactly who ‘they’ are, but boy were they wrong.  The prestigious Johns Hopkins University just announced the opening of a nearly $20 million dollar research center to study psychedelic medicines.  The announcement from Johns Hopkins is arguably the single biggest acknowledgment that Western Society has been embarrassingly wrong about psychedelics all along.  Research trials forthcoming from the new research center include the use of psychedelics to treat addiction, anorexia, Alzheimer’s related distress and cognitive impairment, depression, PTSD, ...

by Edward W. Wilson, PhD Kindle edition available on Amazon Print edition, 66 pages, available here. Preface by Tom Horvath, PhD (reprinted here by permission)   The psychological development of children is well studied. We know what children at different developmental levels can accomplish, and just as importantly, what they cannot accomplish.  The psychological development of adults has been studied much less, and the emerging knowledge that psychologists have on this subject has not become widely known. It doesn’t take a psychologist to know, for instance, that a situation that might lead to a temper tantrum in a two year old, should not lead to a tantrum in a teenager. However, because adults all look “grown up,” we may not realize how differently adults c...

by Tom Horvath, PhD., ABPP This blog is addressed to psychotherapists who do not view themselves as capable of providing addiction treatment. Many (if not most) therapists have this perspective. However, as I have suggested for many years, individual therapy (possibly supplemented by couple’s and family therapy) is the setting of choice for most individuals with addictive problems, and therapists should learn to address these problems. Unfortunately, many therapists lack the confidence even to learn about addiction treatment. Therapists already know most of what they need to know for basic addiction treatment. They also need some basic information about addiction and recovery. In an effort to boost the confidence of these therapists, below are the principles they would keep in min...